Vor Bio
Hiring · 4 open jobsGeneral information
Vor Bio develops therapies for autoimmune diseases, aiming to correct the underlying biology rather than just control symptoms. Its lead product, telitacicept, is a first-in-class BAFF/APRIL inhibitor designed to rebalance immunity and deliver consistent clinical benefit.
Telitacicept has 5 approvals in China across multiple autoimmune conditions, treating tens of thousands of patients there commercially. Jean-Paul Kress, MD serves as Chief Executive Officer and Chairman.1
Open jobs
4 open · updated todayPage 1 of 1, most recently added first · Download (CSV)2
Want to know which of these 4 jobs are worth your time? Upload your CV and we'll score how well you match each one before you apply. It's free.
Score your CV for free before you applySimilar companies
Common questions
Is Vor Bio hiring now?
Yes. There are 4 open jobs.
Hiring trend: available after 60 days of clean history · tracking since August 2026. Velocity stats appear after 60 days of clean history. We're on day 28.
Interview OS
Company pages built from direct checks of real hiring systems.
Notes & sources
- 1. Company description. Written by InterviewOS from Vor Bio's public materials and press coverage; facts are checked against the sources below.
- 2. Live counts. Deduplicated live listings observed daily on Vor Bio's own hiring system; last check October 28, 2026. Stale and syndicated posts on aggregator sites are not counted.
Sources
vorbio.com
About the data
Report a data issue with this page